Beginner Portfolio Update..re-entered a position of a company with pending catalysts at $2.16 here. Catalysts are on deck over the next few weeks. Traded it from $1.91 to $2.35 yesterday for a 23% gain. It closed at $2.35 yesterday as well.
Alert..re-entered $SYN at $2.16 for a solid starter trade. Will add on pullbacks. Catalysts are upcoming that will be strong for the company.
Mr. Riley added that near-term calendar events include a planned September 12th presentation at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis Meeting (ACTRIMS-ECTRIMS) in Boston of additional Trimesta MS data, including important new findings in cognitive function, and a Company-sponsored IBS Investor Day planned for September 16th in NYC which will include clinical presentations by Mark Pimentel, M.D., FRCP(C) of Cedars-Sinai Medical Center, the lead investigator of our 505(b)(2) compound, SYN-010 for constipation-predominant irritable bowel syndrome (C-IBS).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.